Tweet Group


Apr 01

Testing & Diagnosis
Vaccines
Children
Treatments
Immunity
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
SARS-CoV-2 entry is mediated by the spike (S) glycoprotein which contains the receptor-binding domain (RBD) and the N-terminal domain (NTD) as the two main targets of neutralizing antibodies...
https://www.biorxiv.org/content/10.1101/2021.03.31.437925v1
The Veesler Lab @veeslerlab - Thu Apr 01
The #SARSCoV2 CAL20.C (B.1.427/B.1.429) variant is skyrocketing in California. We describe how it evades the host immune response with @DavideCorti6 @LucaPiccoli9 Led by @Dr_MattMcCallum, Jessica Bassi, Anna De Marco, Alex Chen & @coronalexington 1/7 biorxiv.org/content/10.110…
289 521 Open Tweet
7 expert retweets
Expert replies & quotes